言語:
日文
English
簡体中文
繁體中文
ヘルプ
ログイン
ホームページ
スイッチ:
ラベル
|
MARC形式
|
国際標準書誌記述(ISBD)
Metabolic effects of psychotropic dr...
~
Leonard, B. E.
Metabolic effects of psychotropic drugs[electronic resource] /
レコード種別:
言語・文字資料 (印刷物) : 単行資料
[NT 15000414] null:
615/.788
タイトル / 著者:
Metabolic effects of psychotropic drugs/ volume editors, J. Thakore, B.E. Leonard.
その他の著者:
Thakore, Jogin H.,
出版された:
Basel : : S. Karger,, 2009
記述:
1 online resource : : ill. (some col.)
注記:
New insights into endocrine and obesity-related consequences of serious mental illness and their psychopharmacology
主題:
Psychotropic drugs - Side effects.
主題:
Metabolic syndrome.
主題:
Schizophrenia - Chemotherapy
主題:
Psychotropic Drugs - adverse effects.
主題:
Psychotropic Drugs - metabolism.
主題:
Mental Disorders - drug therapy.
国際標準図書番号 (ISBN) :
9783805590020
[NT 15000227] null:
Includes bibliographical references and indexes.
[NT 15000229] null:
Major depression and bipolar disorder are chronic enduring serious mental illnesses (SMI) with devastating effects on psychosocial functioning and may culminate in suicide. Over the past years, it has become apparent that subjects with these conditions can also develop the metabolic syndrome, which is a series of obesity-related physical conditions with an endocrine basis. This book brings together reviews that help put into context exactly why subjects with SMI develop obesity, prediabetic status, overt type 2 diabetes mellitus and related cardiovascular events. The relationship between prolactin and bone mineral density in subjects under medical treatment and the underlying dopaminergic mechanisms as well as the immunological changes occurring as an integral part of SMI and their effects on endocrine function are discussed and reviewed. Psychiatrists, diabetologists, cardiologists, family practitioners, public health physicians as well as basic science researchers will find valuable guidelines when screening for type 2 diabetes mellitus and cardiovascular disease in SMI.
電子資源:
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=240013
Metabolic effects of psychotropic drugs[electronic resource] /
Metabolic effects of psychotropic drugs
[electronic resource] /volume editors, J. Thakore, B.E. Leonard. - Basel :S. Karger,2009 - 1 online resource :ill. (some col.) - Modern trends in pharmacopsychiatry,v.261662-4505 ;. - Modern trends in pharmacopsychiatry ;v.26..
New insights into endocrine and obesity-related consequences of serious mental illness and their psychopharmacology
Includes bibliographical references and indexes.
Major depression and bipolar disorder are chronic enduring serious mental illnesses (SMI) with devastating effects on psychosocial functioning and may culminate in suicide. Over the past years, it has become apparent that subjects with these conditions can also develop the metabolic syndrome, which is a series of obesity-related physical conditions with an endocrine basis. This book brings together reviews that help put into context exactly why subjects with SMI develop obesity, prediabetic status, overt type 2 diabetes mellitus and related cardiovascular events. The relationship between prolactin and bone mineral density in subjects under medical treatment and the underlying dopaminergic mechanisms as well as the immunological changes occurring as an integral part of SMI and their effects on endocrine function are discussed and reviewed. Psychiatrists, diabetologists, cardiologists, family practitioners, public health physicians as well as basic science researchers will find valuable guidelines when screening for type 2 diabetes mellitus and cardiovascular disease in SMI.
ISBN: 9783805590020Subjects--Topical Terms:
402096
Psychotropic drugs
--Side effects.
LC Class. No.: RM315 / .M456 2009
Dewey Class. No.: 615/.788
National Library of Medicine Call No.: W1 / MO168P v.26 2009
Metabolic effects of psychotropic drugs[electronic resource] /
LDR
:02143cam a2200277 a 4500
001
350397
003
SZ-BaSKA
005
20110603112133.0
006
m d
007
cr cn|||||||||
008
111219s2009 sz a ob 001 0 eng d
020
$a
9783805590020
035
$a
240013
040
$a
szbaska
050
0 0
$a
RM315
$b
.M456 2009
050
4
$a
RC483
$b
.M6 v. 26
060
1 0
$a
W1
$b
MO168P v.26 2009
060
1 0
$a
QV 77.2
$b
M587 2009
082
0 0
$a
615/.788
$2
22
245
0 0
$a
Metabolic effects of psychotropic drugs
$h
[electronic resource] /
$c
volume editors, J. Thakore, B.E. Leonard.
260
$a
Basel :
$b
S. Karger,
$c
2009
300
$a
1 online resource :
$b
ill. (some col.)
490
1
$a
Modern trends in pharmacopsychiatry,
$x
1662-4505 ;
$v
v.26
500
$a
New insights into endocrine and obesity-related consequences of serious mental illness and their psychopharmacology
504
$a
Includes bibliographical references and indexes.
520
$a
Major depression and bipolar disorder are chronic enduring serious mental illnesses (SMI) with devastating effects on psychosocial functioning and may culminate in suicide. Over the past years, it has become apparent that subjects with these conditions can also develop the metabolic syndrome, which is a series of obesity-related physical conditions with an endocrine basis. This book brings together reviews that help put into context exactly why subjects with SMI develop obesity, prediabetic status, overt type 2 diabetes mellitus and related cardiovascular events. The relationship between prolactin and bone mineral density in subjects under medical treatment and the underlying dopaminergic mechanisms as well as the immunological changes occurring as an integral part of SMI and their effects on endocrine function are discussed and reviewed. Psychiatrists, diabetologists, cardiologists, family practitioners, public health physicians as well as basic science researchers will find valuable guidelines when screening for type 2 diabetes mellitus and cardiovascular disease in SMI.
650
0
$a
Psychotropic drugs
$x
Side effects.
$3
402096
650
0
$a
Metabolic syndrome.
$3
438630
650
0
$a
Schizophrenia
$x
Chemotherapy
$x
Complications.
$3
438631
650
1 2
$a
Psychotropic Drugs
$x
adverse effects.
$3
372105
650
1 2
$a
Psychotropic Drugs
$x
metabolism.
$3
438632
650
2 2
$a
Mental Disorders
$x
drug therapy.
$3
372107
700
1
$a
Thakore, Jogin H.,
$d
1962-
$3
438627
700
1
$a
Leonard, B. E.
$3
438628
830
0
$a
Modern trends in pharmacopsychiatry ;
$v
v.26.
$3
438629
856
4 0
$u
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=240013
~に基づいて 0 論評
マルチメディア (複合媒体資料)
マルチメディアファイル
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=240013
論評
論評を追加
あなたの考えを共有してください。
Export
受取館
処理
...
パスワードを変更する
ログイン